Search

Search Constraints

You searched for: Author/Creator Conte, Michael

Search Results

4. Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. (20th September 2013)

5. Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Issue 8 (1st June 2017)

8. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial. Issue 14 (12th August 2021)

9. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial. Issue 14 (5th October 2021)

10. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial: Presented at the 2022 Vascular Annual Meeting of the Society for Vascular Surgery, Boston, MA, June 15-18, 2022. (December 2022)